October 3, 2021, 4:20 p.m. (ChST)

 COVID-19 Updates: 49 Hospitalized; Preliminary Test Results: 110 New Cases;

Pfizer-BioNTech COVID-19 Booster Shots Available

49 Hospitalized for COVID-19 – 29 Unvaccinated

Preliminary COVID-19 Test Results: 110 New Cases

Today, the Department of Public Health and Social Services (DPHSS) reported a preliminary case count of 110 new cases of COVID-19 from 969 specimens analyzed on October 2. Additional results are pending analysis and submission from other clinics and will be reported on Monday, October 4. To date, there have been a total of 15,362 officially reported cases, 198 deaths, 3,792 cases in active isolation, and 11,372 not in active isolation. As of October 1, the CAR Score is 25.4.

Pfizer-BioNTech COVID-19 Booster Shots Available 

Booster Shots are available at the University of Guam Calvo Field House for people who had a normal immune response to the first two doses of the Pfizer-BioNTech COVID-19 vaccine, but because of time, antibody levels are beginning to wane. The Pfizer-BioNTech COVID-19 vaccine is the only FDA authorized vaccine to administer as a booster. The following groups of people are eligible for a booster shot of Pfizer-BioNTech if they completed the Pfizer-BioNTech series (first two doses) and it has been 6 months or more since the second dose:

• Anyone age 65+

• Anyone age 18+ with underlying medical conditions

• Anyone 18+ with an elevated risk of COVID-19 exposure and transmission due to their occupation (e.g. healthcare workers, law enforcement, fire, K-12 teachers and support staff, university faculty, daycare employees, food and agriculture workers, manufacturing workers, USPS workers, corrections workers, public transit workers, grocery store workers) or living settings

If eligible, please make your Booster Shot appointment at tinyurl.com/vaxguam. Walk-ins are accepted but should be prepared for longer wait times. 

For more information, visit dphss.guam.gov/covid-19-testing. 

Guam COVID-19 Vaccination Update

As of October 2, 151 additional residents received their first dose in a two-dose series, 29 residents received their dose in the single-dose series, and an additional 371 residents have become fully vaccinated. To date, a total of 120,300 (88.27%) of Guam’s eligible population (residents 12 years and older) is fully vaccinated. This percentage includes 10,808 fully vaccinated residents between the ages of 12 – 17, and 109,492 fully vaccinated adults. 1,552 doses of the Pfizer-BioNTech vaccine have been administered to eligible residents as either a booster or an additional dose. 18 doses of the Moderna vaccine have been administered as an additional dose to eligible residents.

-###-